Navigation Links
Reportlinker Adds Probiotics and Prebiotics in Clinical Nutrition
Date:5/3/2011

NEW YORK, May 3, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Probiotics and Prebiotics in Clinical Nutrition

http://www.reportlinker.com/p0488805/Probiotics-and-Prebiotics-in-Clinical-Nutrition.html

Introduction

Overall sales of clinical nutrition products are rising with an aging population in the US and EU as well as rising incidence of illnesses and conditions that require clinical nutrition. But sales of clinical nutrition products containing probiotics and prebiotics are outpacing sales of conventional clinical nutrition products, opening up a new market that is dominated by a handful of players.

Features and benefits

* Understand the clinical nutrition market and broad trends affecting product development and usage.

* Analyze the unmet need for pro/prebiotic clinical nutrition products and what is the supporting clinical data for product benefits?

* Identify the key players in the pro/prebiotic clinical nutrition market and the leading products in the market.

* Forecast the growth of the pro/prebiotic clinical nutrition market by users and product sales in the EU and the US.

* Assess the future of probiotics and prebiotics in clinical nutrition and the potential product development opportunities.

Highlights

Nearly all of the major manufacturers of enteral nutrition products – Abbott Nutrition, Danone, Fresenius Kabi and Nestle – are currently working to expand their offerings of products containing probiotics and prebiotics. Currently, several clinical nutrition products are formulated with prebiotics and one major product contains probiotics.

Several special patient populations are especially good candidates for clinical nutrition products containing probiotics and/or prebiotics as they have specific and/or greater nutritional needs than non-elderly adults. They include the elderly, patients with compromised gastrointestinal systems, the critically ill and infants.

Although there is interest and activity in the development of enteral nutrition products containing probiotics, a lack of basic research establishing the clinical performance of probiotics in enteral nutrition patients is limiting further new product activity.

Your key questions answered

* Why are clinical nutrition products now incorporating probiotic and prebiotic ingredients? What types products are most amenable to reformulation?

* What benefits can probiotic and prebiotic ingredients provide in clinical nutrition products that is not otherwise available?

* What clinical nutrition products currently contain probiotic and prebiotic ingredients?

* Which patient groups/market segments are most attractive for these products?

* What is the forecast growth of clinical nutrition products containing probiotics and prebiotics and what are the drivers/inhibitors of R&D?

Executive Summary

Introduction to clinical nutrition

Probiotics and their role in healthcare

Usage of probiotics and prebiotics in clinical nutrition

Activities of the major players in probiotics and prebiotics

About the author

Disclaimer

Introduction to clinical nutrition

Summary

Introduction

Major types of clinical nutrition

Enteral nutrition

Parenteral nutrition

Infant nutrition

Patient populations

Cancer patients

Gastrointestinal disease patients

AIDS patients

Patients with neuromuscular conditions

Malnutrition patients

Other clinical nutrition patients

Environments for clinical nutrition

Inpatient environments

Outpatient environments

Regulation of clinical nutrition products

US

EU

Insurance coverage

EU

User populations

Conclusions

The evolving role of probiotics in healthcare

Summary

Introduction

Probiotics

Prebiotics

Synbiotics

Factors affecting probiotic levels in the human body

Declining levels of probiotics in food

Types of probiotic organisms

Safety issues

Probiotics

Prebiotics

Benefits of probiotics and prebiotics

Anxiety

Colon cancer

Diarrhea

Gastrointestinal disease and diarrhea

Helicobacter pylori

Hypertension

Immune system function

Lactose intolerance

Mineral absorption

Urinary tract infections

Yeast infections

Disadvantages of probiotics

Probiotics

Prebiotics

Patent issues

Regulation of probiotic and prebiotic products

US

EU

Other industry issues

Standards

Testing protocols

Consumers' ability to self-diagnose

Current products

Probiotics

Prebiotics

User populations

Probiotics

Prebiotics

Conclusions

Usage of probiotics and prebiotics in clinical nutrition

Summary

Introduction

Special populations

The elderly

Patients with compromised gastrointestinal systems

The critically ill

Infants

Safety issues

Current products

Products under development

Parenteral nutrition

Infant nutrition

Sales forecasts, 2010 - 2015

Total probiotic supplement sales by region, 2010 - 2015

Total prebiotic supplement sales by region, 2010–2015

Sales of clinical nutrition products containing probiotics, 2010–2015

Sales of clinical nutrition products containing prebiotics, 2010 - 2015

Conclusions

Activities of the major players in probiotic and prebiotic clinical nutrition products

Summary

Introduction

Leading suppliers of clinical nutrition products

Abbott Laboratories

B. Braun

Danone

Fresenius Kabi

Nestle

Pfizer

The future of probiotics and prebiotics in clinical nutrition

Conclusions

Appendix

Scope

Methodology

Secondary research

Glossary/Abbreviations

Bibliography/References

To order this report:

: Probiotics and Prebiotics in Clinical Nutrition

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Triple Analysis: Leukemia, Pancreatic Cancer and Prostate Cancer
2. Reportlinker Adds Cancer Reports Bundle
3. Reportlinker Adds Medical Imaging Technologies for Oncology Diagnostics: The Global Market
4. Reportlinker Adds Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies
5. Reportlinker Adds Advanced Lung Cancer in Patient Smoker with Squamous Cell: Clinical Insights from a US Oncologists Survey
6. Reportlinker Adds Advanced Lung Cancer with EGFR Mutation Positive Adenocarcinoma
7. Reportlinker Adds Pharmaceutical Key Trends 2011 - Prescription Pharmaceutical Sales Overview
8. Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify
9. Reportlinker Adds Pharmaceutical Key Trends 2011 - Biosimilar Market Overview
10. Reportlinker Adds Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry
11. Reportlinker Adds Forecast Insight: Antibacterials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market by Manufacturers, ... and analysed the potential of Global Effective Microorganisms (EM) Market ... growth factors. The report identifies and analyses the emerging trends ... market. ... and Figures, 6 Major Company Profiles, spread across 124 pages ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... Somnoware, a leading provider ... Online(TM), which enables sleep physicians to create and edit their interpretation reports. This ... provides a familiar interface that does not require additional training to use. It ...
(Date:4/28/2017)... NY (PRWEB) , ... April 28, 2017 , ... ... Laboratory to expanded distribution of the GlycoMark test throughout the Northeast U.S. ... hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically proven one- ...
(Date:4/28/2017)... york (PRWEB) , ... April 28, 2017 , ... ... to announce that Aditya Patel M.D. has joined the revolutionary endoscopic practice under ... and board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique created ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and ... drug safety and minimize the cost of development. In this webinar, sponsored by ... cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at ... ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled in ... activity and sleep monitoring solutions for the global scientific community. The company’s new ...
Breaking Medicine News(10 mins):